IDiyas

For the Inventor, By the Inventor

Somerville, MA, United States of America

Christopher Michael Adams

USPTO Granted Patents = 25 


 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 127(Granted Patents)


Location History:

  • Verdi, NV (US) (2000 - 2001)
  • Somerville, MA (US) (2011 - 2019)
  • Arlington, MA (US) (2017 - 2022)

Company Filing History:

goldMedal23 out of 3,923 
 
Novartis Ag
 patents
silverMedal2 out of 832,680 
Other
 patents

Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):
1. 12433949 - Sustained release delivery systems comprising traceless linkers (2025-10-07),
2. 11389541 - Sustained delivery of angiopoetin-like 3 polypeptides (2022-07-19),
3. 10751417 - Sustained release delivery systems comprising traceless linkers (2020-08-25),
4. 10550102 - Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators (2020-02-04),
5. 10537563 - Methods for treating ocular disease using inhibitors of CSF-1R (2020-01-21),
6. 10316020 - Indane derivatives and the use thereof as soluble guanylate cyclase activators (2019-06-11),
7. 10208018 - Indane and indoline derivatives and the use thereof as soluble guanylate cyclase activators (2019-02-19),
8. 10174006 - Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease (2019-01-08),
9. 10093663 - Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof (2018-10-09),
10. 9957254 - Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators (2018-05-01),
11. 9765067 - Thiophen-2-yl-pyridin-2-yl-1H-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators (2017-09-19),
12. 9682968 - Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof (2017-06-20),
13. 9676728 - 2-benzyl-benzimidazole complement factor B inhibitors and uses thereof (2017-06-13),
14. 9505755 - Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators (2016-11-29),
15. 9475806 - Complement factor B inhibitors and uses there of (2016-10-25),

Title: Innovator Spotlight: Christopher Michael Adams

Introduction:

Christopher Michael Adams, a prolific inventor based in Somerville, MA (US), is making waves in the field of drug delivery systems with his groundbreaking inventions. With an impressive portfolio of 22 patents, Adams has established himself as a leading figure in the industry.

Latest Patents:

Among his latest patents is the innovative "Sustained delivery of angiopoetin-like 3 polypeptides," which focuses on drug delivery systems for delivering biologically active agents with sustained release properties. Another notable invention is the "Sustained release delivery systems comprising traceless linkers," showcasing Adams' expertise in developing cutting-edge pharmaceutical compositions.

Career Highlights:

Currently employed at Novartis AG, Adams continues to drive innovation and push the boundaries of drug delivery technology. His work at Novartis AG reflects his commitment to advancing healthcare through transformative inventions.

Collaborations:

Throughout his career, Adams has collaborated with talented individuals such as Takeru Ehara and Nan Ji, demonstrating his ability to work effectively in multidisciplinary teams. These collaborations have undoubtedly contributed to the success of his innovative projects.

Conclusion:

In conclusion, Christopher Michael Adams stands out as a visionary inventor who is shaping the future of drug delivery systems. His dedication to excellence and pioneering spirit make him a key player in the industry, and his patents are a testament to his ingenuity and passion for innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…